Skip to main content
. 2014 Jul 25;5(21):10460–10472. doi: 10.18632/oncotarget.2260

Figure 5. Individual patient samples respond differently to BEZ235, BGT226 and everolimus.

Figure 5

Western blots of cells recovered from the spleens of mice treated with the BEZ235, BGT226 for the indicated times prior to sacrifice. Treatment was administered when the estimated survival time for untreated animals was less than 2 weeks.